Literature DB >> 24085627

Comparative evaluation of gastroulcerogenic potential of nitrogen isoforms of salicyl alcohol and aspirin in rats: biochemical and histological study.

Gowhar Ali1, Fazal Subhan, Nazar Ul Islam, Nasir Ullah, Muhammad Shahid, Sami Ullah, Ihsan Ullah, Rehmat Shah, Ikhtiar Khan, Robert D E Sewell, Ghulam Abbas.   

Abstract

The aim of the current study was to explore in vivo any relative gastroulcerogenic prospective propensity of newly synthesized nitrogen containing derivatives of salicyl alcohol; compound (I) [1-(2-hydroxybenzyl)piperidinium chloride], compound (II) [4-carbamoyl-1-(2-hydroxybenzyl)piperidinium chloride] and aspirin in albino rats. The experimental groups received the following oral treatments daily for 6 days: group I saline control; group II, standard (aspirin) treatment group [150 mg/kg of body weight]; group III, test (compound I) treatment group [100, 150 mg/kg]; group IV, test (compound II) treatment group [100, 150 mg/kg]. The results showed that in the case of the aspirin treated group and compound (I) [150 mg/kg], there was a significant increase in gastric volume, free acidity, total acidity, ulcer score and a decrease in gastric pH. Furthermore, histopathological examination of gastric mucosa of these treated groups revealed detectable morphological changes. Utilizing the same protocol, synthetic compound (I) [100 mg/kg] and (II) [100, 150 mg/kg] exhibited no statistically significant ulcerogenic or cytotoxic properties. A cyclooxygenase (COX) selectivity test indicated the preferential inhibition of COX-I and COX-II enzymes by compounds (I) and (II). This study therefore indicates that these synthetic compounds may possess reduced ulcerogenic potential and could be a functional substitute to aspirin.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24085627     DOI: 10.1007/s12272-013-0245-9

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  1 in total

1.  Olanzapine induced biochemical and histopathological changes after its chronic administration in rats.

Authors:  Rehmat Shah; Fazal Subhan; Gowhar Ali; Ihsan Ullah; Sami Ullah; Muhammad Shahid; Nisar Ahmad; Khwaja Fawad
Journal:  Saudi Pharm J       Date:  2015-06-18       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.